These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 30260061)

  • 21. Prediction of HIV peptide epitopes by a novel algorithm.
    Roberts CG; Meister GE; Jesdale BM; Lieberman J; Berzofsky JA; De Groot AS
    AIDS Res Hum Retroviruses; 1996 May; 12(7):593-610. PubMed ID: 8743085
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evidence of differential HLA class I-mediated viral evolution in functional and accessory/regulatory genes of HIV-1.
    Brumme ZL; Brumme CJ; Heckerman D; Korber BT; Daniels M; Carlson J; Kadie C; Bhattacharya T; Chui C; Szinger J; Mo T; Hogg RS; Montaner JS; Frahm N; Brander C; Walker BD; Harrigan PR
    PLoS Pathog; 2007 Jul; 3(7):e94. PubMed ID: 17616974
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PREDIVAC: CD4+ T-cell epitope prediction for vaccine design that covers 95% of HLA class II DR protein diversity.
    Oyarzún P; Ellis JJ; Bodén M; Kobe B
    BMC Bioinformatics; 2013 Feb; 14():52. PubMed ID: 23409948
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In silico rational design of a novel tetra-epitope tetanus vaccine with complete population coverage using developed immunoinformatics and surface epitope mapping approaches.
    Bazmara S; Shadmani M; Ghasemnejad A; Aghazadeh H; Pooshang Bagheri K
    Med Hypotheses; 2019 Sep; 130():109267. PubMed ID: 31383332
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of CD4+ T-cell epitope and investigation of HLA distribution for the immunogenic proteins of Burkholderia pseudomallei using in silico approaches - A key vaccine development strategy for melioidosis.
    Swetha RG; Sandhya M; Ramaiah S; Anbarasu A
    J Theor Biol; 2016 Jul; 400():11-8. PubMed ID: 27086038
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epitope-based peptide vaccine design and target site depiction against Ebola viruses: an immunoinformatics study.
    Khan MA; Hossain MU; Rakib-Uz-Zaman SM; Morshed MN
    Scand J Immunol; 2015 Jul; 82(1):25-34. PubMed ID: 25857850
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In silico design and in vitro expression of novel multiepitope DNA constructs based on HIV-1 proteins and Hsp70 T-cell epitopes.
    Akbari E; Kardani K; Namvar A; Ajdary S; Ardakani EM; Khalaj V; Bolhassani A
    Biotechnol Lett; 2021 Aug; 43(8):1513-1550. PubMed ID: 33987776
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification and antigenicity of broadly cross-reactive and conserved human immunodeficiency virus type 1-derived helper T-lymphocyte epitopes.
    Wilson CC; Palmer B; Southwood S; Sidney J; Higashimoto Y; Appella E; Chesnut R; Sette A; Livingston BD
    J Virol; 2001 May; 75(9):4195-207. PubMed ID: 11287569
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fine specificity and cross-clade reactivity of HIV type 1 Gag-specific CD4+ T cells.
    Norris PJ; Moffett HF; Brander C; Allen TM; O'Sullivan KM; Cosimi LA; Kaufmann DE; Walker BD; Rosenberg ES
    AIDS Res Hum Retroviruses; 2004 Mar; 20(3):315-25. PubMed ID: 15117455
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In silico analysis of MHC-I restricted epitopes of Chikungunya virus proteins: Implication in understanding anti-CHIKV CD8(+) T cell response and advancement of epitope based immunotherapy for CHIKV infection.
    Pratheek BM; Suryawanshi AR; Chattopadhyay S; Chattopadhyay S
    Infect Genet Evol; 2015 Apr; 31():118-26. PubMed ID: 25643869
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clustering patterns of cytotoxic T-lymphocyte epitopes in human immunodeficiency virus type 1 (HIV-1) proteins reveal imprints of immune evasion on HIV-1 global variation.
    Yusim K; Kesmir C; Gaschen B; Addo MM; Altfeld M; Brunak S; Chigaev A; Detours V; Korber BT
    J Virol; 2002 Sep; 76(17):8757-68. PubMed ID: 12163596
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A common conserved peptide harboring predicted T and B cell epitopes in domain III of envelope protein of Japanese Encephalitis Virus and West Nile Virus for potential use in epitope based vaccines.
    Slathia PS; Sharma P
    Comp Immunol Microbiol Infect Dis; 2019 Aug; 65():238-245. PubMed ID: 31300121
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prediction of Epitope-Based Peptide Vaccine Against the Chikungunya Virus by Immuno-informatics Approach.
    Anwar S; Mourosi JT; Khan MF; Hosen MJ
    Curr Pharm Biotechnol; 2020; 21(4):325-340. PubMed ID: 31721709
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human immunodeficiency virus type 1 specific cytotoxic T lymphocyte responses in Chinese infected with HIV-1 B'/C Recombinant (CRF07_BC).
    Chen J; Hong K; Jia M; Liu H; Zhang Y; Liu S; Zhang X; Zhao H; Peng H; Ma P; Xing H; Ruan Y; Williams KL; Yu XG; Altfeld M; Walker BD; Shao Y
    Retrovirology; 2007 Aug; 4():62. PubMed ID: 17727734
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunoinformatics Approach for Epitope-Based Peptide Vaccine Design and Active Site Prediction against Polyprotein of Emerging Oropouche Virus.
    Adhikari UK; Tayebi M; Rahman MM
    J Immunol Res; 2018; 2018():6718083. PubMed ID: 30402510
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development and preclinical safety evaluation of a new therapeutic HIV-1 vaccine based on 18 T-cell minimal epitope peptides applying a novel cationic adjuvant CAF01.
    Fomsgaard A; Karlsson I; Gram G; Schou C; Tang S; Bang P; Kromann I; Andersen P; Andreasen LV
    Vaccine; 2011 Sep; 29(40):7067-74. PubMed ID: 21767590
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of cross-clade CTL epitopes in HIV-1 clade A/E-infected individuals by using the clade B overlapping peptides.
    Watanabe K; Murakoshi H; Tamura Y; Koyanagi M; Chikata T; Gatanaga H; Oka S; Takiguchi M
    Microbes Infect; 2013 Nov; 15(13):874-86. PubMed ID: 23968885
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multiple Approaches for Increasing the Immunogenicity of an Epitope-Based Anti-HIV Vaccine.
    Rosa DS; Ribeiro SP; Fonseca SG; Almeida RR; Santana VC; Apostólico Jde S; Kalil J; Cunha-Neto E
    AIDS Res Hum Retroviruses; 2015 Nov; 31(11):1077-88. PubMed ID: 26149745
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of highly conserved and broadly cross-reactive HIV type 1 cytotoxic T lymphocyte epitopes as candidate immunogens for inclusion in Mycobacterium bovis BCG-vectored HIV vaccines.
    Ferrari G; Kostyu DD; Cox J; Dawson DV; Flores J; Weinhold KJ; Osmanov S
    AIDS Res Hum Retroviruses; 2000 Sep; 16(14):1433-43. PubMed ID: 11018863
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design of an Epitope-Based Peptide Vaccine Against the Major Allergen Amb a 11 Using Immunoinformatic Approaches.
    Moten D; Kolchakova D; Todorov K; Mladenova T; Dzhambazov B
    Protein J; 2022 Apr; 41(2):315-326. PubMed ID: 35362839
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.